Order Article Reprints

Bock N, Forouz F, Hipwood L, Clegg J, Jeffery P, Gough M, van Wyngaard T, Pyke C, Adams MN, Bray LJ, et al. GelMA, Click-Chemistry Gelatin and Bioprinted Polyethylene Glycol-Based Hydrogels as 3D Ex Vivo Drug Testing Platforms for Patient-Derived Breast Cancer Organoids. Pharmaceutics. 2023; 15(1):261. https://doi.org/10.3390/pharmaceutics15010261

Bock, Nathalie, Farzaneh Forouz, Luke Hipwood, Julien Clegg, Penny Jeffery, Madeline Gough, Tirsa van Wyngaard, Christopher Pyke, Mark N. Adams, Laura J. Bray, and et al. 2023. "GelMA, Click-Chemistry Gelatin and Bioprinted Polyethylene Glycol-Based Hydrogels as 3D Ex Vivo Drug Testing Platforms for Patient-Derived Breast Cancer Organoids" Pharmaceutics 15, no. 1: 261. https://doi.org/10.3390/pharmaceutics15010261

Bock, N., Forouz, F., Hipwood, L., Clegg, J., Jeffery, P., Gough, M., van Wyngaard, T., Pyke, C., Adams, M. N., Bray, L. J., Croft, L., Thompson, E. W., Kryza, T., & Meinert, C. (2023). GelMA, Click-Chemistry Gelatin and Bioprinted Polyethylene Glycol-Based Hydrogels as 3D Ex Vivo Drug Testing Platforms for Patient-Derived Breast Cancer Organoids. Pharmaceutics, 15(1), 261. https://doi.org/10.3390/pharmaceutics15010261